95 related articles for article (PubMed ID: 2222009)
1. [Study of cellular immunity in patients with Mediterranean visceral leishmaniasis].
Dunan S; Meller C; Kaplanski S; Mary C; Faugère B; Franck J; Toga I; Farnarier C; Quilici M
Ann Soc Belg Med Trop; 1990 Jun; 70(2):83-97. PubMed ID: 2222009
[TBL] [Abstract][Full Text] [Related]
2. Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients.
Meller-Melloul C; Farnarier C; Dunan S; Faugere B; Franck J; Mary C; Bongrand P; Quilici M; Kaplanski S
Parasite Immunol; 1991 Sep; 13(5):531-6. PubMed ID: 1956699
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.
Garg R; Gupta SK; Tripathi P; Naik S; Sundar S; Dube A
Clin Exp Immunol; 2005 Apr; 140(1):149-56. PubMed ID: 15762886
[TBL] [Abstract][Full Text] [Related]
4. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
Tripathi P; Ray S; Sunder S; Dube A; Naik S
Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
[TBL] [Abstract][Full Text] [Related]
5. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively.
Meddeb-Garnaoui A; Toumi A; Ghelis H; Mahjoub M; Louzir H; Chenik M
Vaccine; 2010 Feb; 28(7):1881-6. PubMed ID: 20005858
[TBL] [Abstract][Full Text] [Related]
7. Immunity to visceral leishmaniasis: implications for immunotherapy.
Khadem F; Uzonna JE
Future Microbiol; 2014; 9(7):901-15. PubMed ID: 25156379
[TBL] [Abstract][Full Text] [Related]
8. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
[TBL] [Abstract][Full Text] [Related]
9. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
10. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.
Carvalho EM; Barral A; Pedral-Sampaio D; Barral-Netto M; Badaró R; Rocha H; Johnson WD
J Infect Dis; 1992 Mar; 165(3):535-40. PubMed ID: 1347057
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania.
Carvalho EM; Bacellar OA; Reed S; Barral A; Rocha H
Braz J Med Biol Res; 1988; 21(1):85-92. PubMed ID: 3179584
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.
Carvalho EM; Bacellar O; Barral A; Badaro R; Johnson WD
J Clin Invest; 1989 Mar; 83(3):860-4. PubMed ID: 2522103
[TBL] [Abstract][Full Text] [Related]
16. [Application of monoclonal antibodies against Leishmania donovani, II. Detection of circulating antigen in sera of visceral leishmaniasis before and after treatment].
Qu JQ; Xu YX; Bao YF; Yang YT; Wang JY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(1):21-3. PubMed ID: 2065447
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
Hailu A; van der Poll T; Berhe N; Kager PA
Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
[TBL] [Abstract][Full Text] [Related]
19. Gamma interferon production by lymphocytes from children infected with L. chagasi.
Bacellar O; Barral-Netto M; Badaró R; Carvalho EM
Braz J Med Biol Res; 1991; 24(8):791-5. PubMed ID: 1797267
[TBL] [Abstract][Full Text] [Related]
20. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
